Stephen Saad's Stake In Aspen Slips Below 450 Million

Stephen Saads stake in Aspen Pharmacare drops below 450 million as shares slide 12.82 on the JSE over the past 15 trading days.

Aspens market cap declines to 3.4 billion, impacting shareholder wealth, including a 62.85 million loss for Saad in just two weeks.

Aspen shares drop 11.37 in 2025, turning a 100,000 investment into 88,630, amid broader market pressures.

South African pharma tycoon Stephen Saad, CEO of Aspen Pharmacare, Africas largest pharmaceutical company, has seen the value of his stake in the company drop below 450 million, as the companys shares continue to slide on the Johannesburg Stock Exchange JSE .

Saad, who owns 12.8 percent of the Durban-based drugmakerequivalent to 57,221,750 shareshas lost about R1.23 billion 62.85 million over the past 15 days. This brings the value of his Aspen stake to just 434.35 million.

The recent decline follows a previous loss of 41.15 million between Jan. 31 and Mar. 27 , when the value of his holdings had already fallen to R9.58 billion 525.19 million.

Aspen Pharmacare , founded by Stephen Saad in 1997, has become a prominent player in South Africas pharmaceutical industry, contributing significantly to his wealth. The company operates in more than 115 countries and has experienced steady growth under his leadership.

However, Aspen's share price has fallen by 12.82 on the Johannesburg Stock Exchange over the past 15 days, dropping from R167.59 8.71 on March 10 to R146.11 7.59. This decline has reduced the companys market capitalization to around 3.4 billion, resulting in significant losses for shareholders.